Skip to Main Content

Author Details

Paul Lasko
McGill University. Montreal
1981
136
54
PMIDPaper TitleJournal TitlePublished Year
38038264Functional analysis of the AUG initiator codon context reveals novel conserved sequences that disfavor mRNA translation in eukaryotes.Nucleic Acids Res2024
38038264Functional analysis of the AUG initiator codon context reveals novel conserved sequences that disfavor mRNA translation in eukaryotes.Nucleic Acids Res2024
36695474Eukaryotic translation initiation factor eIF4E-5 is required for spermiogenesis in Drosophila melanogaster.Development2023
36695474Eukaryotic translation initiation factor eIF4E-5 is required for spermiogenesis in Drosophila melanogaster.Development2023
34671974The broader phenotypic spectrum of congenital caudal abnormalities associated with mutations in the caudal type homeobox 2 gene.Clin Genet2022
36150389The piRNA-pathway factor FKBP6 is essential for spermatogenesis but dispensable for control of meiotic LINE-1 expression in humans.Am J Hum Genet2022
34671974The broader phenotypic spectrum of congenital caudal abnormalities associated with mutations in the caudal type homeobox 2 gene.Clin Genet2022
36150389The piRNA-pathway factor FKBP6 is essential for spermatogenesis but dispensable for control of meiotic LINE-1 expression in humans.Am J Hum Genet2022
33423597<i>Drosophila melanogaster</i>: a fruitful model for oncohistones.Fly (Austin)2021
33659928Investigating rare and ultrarare epilepsy syndromes with <i>Drosophila</i> models.Fac Rev2021
33423597<i>Drosophila melanogaster</i>: a fruitful model for oncohistones.Fly (Austin)2021
33406067Ectoderm to mesoderm transition by down-regulation of actomyosin contractility.PLoS Biol2021
34739871Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks.Mol Cell2021
34437552Transgenes of genetically modified animals detected non-invasively via environmental DNA.PLoS One2021
33659928Investigating rare and ultrarare epilepsy syndromes with <i>Drosophila</i> models.Fac Rev2021
34437552Transgenes of genetically modified animals detected non-invasively via environmental DNA.PLoS One2021
34739871Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of antagonistic chromatin marks.Mol Cell2021
33406067Ectoderm to mesoderm transition by down-regulation of actomyosin contractility.PLoS Biol2021
32543002Patterning the Drosophila embryo: A paradigm for RNA-based developmental genetic regulation.Wiley Interdiscip Rev RNA2020
31978041Makorin 1 controls embryonic patterning by alleviating Bruno1-mediated repression of oskar translation.PLoS Genet2020
32543002Patterning the Drosophila embryo: A paradigm for RNA-based developmental genetic regulation.Wiley Interdiscip Rev RNA2020
33166539Unorthodox Mechanisms to Initiate Translation Open Novel Paths for Gene Expression.J Mol Biol2020
31978041Makorin 1 controls embryonic patterning by alleviating Bruno1-mediated repression of oskar translation.PLoS Genet2020
33166539Unorthodox Mechanisms to Initiate Translation Open Novel Paths for Gene Expression.J Mol Biol2020
30715493Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster.Neuro Oncol2019
31551467A ribosomal protein S5 isoform is essential for oogenesis and interacts with distinct RNAs in Drosophila melanogaster.Sci Rep2019
31526762Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.Cancer Cell2019
30715493Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster.Neuro Oncol2019
31526762Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.Cancer Cell2019
31551467A ribosomal protein S5 isoform is essential for oogenesis and interacts with distinct RNAs in Drosophila melanogaster.Sci Rep2019
28796411Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.Clin Transl Sci2018
28796411Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.Clin Transl Sci2018
30011838Recent Developments in Using <i>Drosophila</i> as a Model for Human Genetic Disease.Int J Mol Sci2018
30011838Recent Developments in Using <i>Drosophila</i> as a Model for Human Genetic Disease.Int J Mol Sci2018
27494710The translation factors of Drosophila melanogaster.Fly (Austin)2017
31988931The Canadian Path from Discovery to Implementation of Personalized Medicine Approaches.Biomed Hub2017
28468665Initiating an undiagnosed diseases program in the Western Australian public health system.Orphanet J Rare Dis2017
28771463Dueling RNA-binding proteins promote translational activation.Nat Struct Mol Biol2017
28898674mRNAs on the Move after Lunch.Dev Cell2017
28779316Multiple Functions of the DEAD-Box Helicase Vasa in Drosophila Oogenesis.Results Probl Cell Differ2017
29214566Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Adv Exp Med Biol2017
29158551The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.Eur J Hum Genet2017
27782107'IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases.Eur J Hum Genet2017
27494710The translation factors of Drosophila melanogaster.Fly (Austin)2017
31988931The Canadian Path from Discovery to Implementation of Personalized Medicine Approaches.Biomed Hub2017
28468665Initiating an undiagnosed diseases program in the Western Australian public health system.Orphanet J Rare Dis2017
29158551The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.Eur J Hum Genet2017
29214566Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.Adv Exp Med Biol2017
28779316Multiple Functions of the DEAD-Box Helicase Vasa in Drosophila Oogenesis.Results Probl Cell Differ2017
28771463Dueling RNA-binding proteins promote translational activation.Nat Struct Mol Biol2017
  • 1 - 50 of 272

Recommended Authors

Deirdre C Tatomer
University of Pennsylvania Perelman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Alexandre S Cristino
Griffith Institute for Drug Discovery, Griffith University
Career Start Year 2006
Number of shared co-authors 4
Donghui Yang-Zhou
Blavatnik Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Ajay A Vashisht
David Geffen School of Medicine, University of California los angeles
Career Start Year 2005
Number of shared co-authors 1
Tianyi Zhang
National Institute on Aging, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Andreas Rechtsteiner
University of California
Career Start Year 2004
Number of shared co-authors 7
Min Liu
Xiamen University
Career Start Year 2004
Number of shared co-authors 0
Yanmei Huang
The First Affiliated Hospital, Hengyang Medical School, University of South China
Career Start Year 2002
Number of shared co-authors 16
Miriam I Rosenberg
Technion-Israel Institute of Technology
Career Start Year 2002
Number of shared co-authors 4
Gilberto Dos Santos
Harvard University
Career Start Year 2001
Number of shared co-authors 6
Bingbing Yuan
Whitehead Institute for Biomedical Research
Career Start Year 2000
Number of shared co-authors 0
Ekaterina Voronina
University of Montana
Career Start Year 1997
Number of shared co-authors 7
Marco Blanchette
Stowers Institute for Medical Research
Career Start Year 1997
Number of shared co-authors 5
Asifa Akhtar
Max Planck Institute of Immunobiology and Epigenetics
Career Start Year 1996
Number of shared co-authors 2
Kristin C Gunsalus
Center for Genomics and Systems Biology, New York University Abu Dhabi (NYUAD)
Career Start Year 1995
Number of shared co-authors 5
Hans-Rudolf Hotz
Friedrich Miescher Institute for Biomedical Research
Career Start Year 1994
Number of shared co-authors 1
Giovanni Bosco
Geisel School of Medicine at Dartmouth
Career Start Year 1994
Number of shared co-authors 1
Andrew J Schroeder
Harvard Medical School
Career Start Year 1993
Number of shared co-authors 19
Sarah B Pierce
University of Washington
Career Start Year 1987
Number of shared co-authors 3
Ethan Bier
University of California
Career Start Year 1985
Number of shared co-authors 0
J M Axton
Whitehead Institute
Career Start Year 1985
Number of shared co-authors 2
Bruce A Hay
University Hospital Wishaw
Career Start Year 1984
Number of shared co-authors 24
Hugo J Bellen
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 22
Juan Botas
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 10
Ann S Hammonds
Lawrence Berkeley National Laboratory
Career Start Year 1982
Number of shared co-authors 8
Iswar K Hariharan
University of California berkeley
Career Start Year 1981
Number of shared co-authors 23
Barbara T Wakimoto
University of Washington Seattle
Career Start Year 1979
Number of shared co-authors 7
Donald C Rio
University of California berkeley
Career Start Year 1979
Number of shared co-authors 3
Claude Desplan
New York University
Career Start Year 1977
Number of shared co-authors 6
Patrick H O'Farrell
University of California san francisco
Career Start Year 1971
Number of shared co-authors 24

Collaborators

Hong Han
Hangzhou City University
Co-authored papers 7
Gareth Baynam
King Edward Memorial Hospital
Co-authored papers 6
Michael Ashburner
University of Cambridge
Co-authored papers 5
Travis Thomson
Co-authored papers 5
Hugh Dawkins
The University of Notre Dame Australia
Co-authored papers 5
Hanns Lochm??ller
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 4
Christopher P Austin
St. George's University Medical School
Co-authored papers 4
Kym M Boycott
Children's Hospital of Eastern Ontario
Co-authored papers 4
Petra Kaufmann
Novartis Gene Therapies
Co-authored papers 4
Yann Le Cam
Co-authored papers 4
Domenica Taruscio
National Center for Rare Diseases, Istituto Superiore di Sanita
Co-authored papers 3
William A Gahl
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 3
Stephen C Groft
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 3
Kenjiro Kosaki
Center for Medical Genetics, Keio University School of Medicine
Co-authored papers 3
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 3
Lyn Schofield
King Edward Memorial Hospital for Women Perth
Co-authored papers 2
Cathy Kiraly-Borri
Princess Margaret Hospital
Co-authored papers 2
Jennie Slee
King Edward Memorial Hospital
Co-authored papers 2
Caroline E Walker
University of London
Co-authored papers 2
Anne Hawkins
Stanford University School of Medicine
Co-authored papers 2
Fiona McKenzie
King Edward Memorial Hospital
Co-authored papers 2
William M Gelbart
University of California Los Angeles
Co-authored papers 2
John Beilby
University of Western Australia
Co-authored papers 2
Alexey L Arkov
Co-authored papers 2
Ana Rath
INSERM
Co-authored papers 2
Stephanie Broley
King Edward Memorial Hospital
Co-authored papers 2
Jack Goldblatt
King Edward Memorial Hospital for Women
Co-authored papers 2
John S Mattick
Australia UNSW RNA Institute
Co-authored papers 2
Tarun Weeramanthri
University of Western Australia
Co-authored papers 2
Sharron Townshend
King Edward Memorial Hospital
Co-authored papers 2
Release 1.2